Notwithstanding, studies are still conducted on limited cohorts, therefore results need to be consolidated by larger cohorts and longitudinal studies, evaluating the association between S100b changes, volume of tissue damage and the functional or cognitive outcome over the post-stroke phases. The gene discussed is S100B; the disease is Stroke.